These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31067516)

  • 41. Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.
    Mortezaee K; Majidpoor J; Kharazinejad E
    Med Oncol; 2022 Sep; 39(12):193. PubMed ID: 36071302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype.
    Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
    Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications.
    Zare M; Bastami M; Solali S; Alivand MR
    J Cell Physiol; 2018 May; 233(5):3729-3744. PubMed ID: 28771724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation.
    Yeo CD; Kang N; Choi SY; Kim BN; Park CK; Kim JW; Kim YK; Kim SJ
    Korean J Intern Med; 2017 Jul; 32(4):589-599. PubMed ID: 28704917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
    Marie-Egyptienne DT; Lohse I; Hill RP
    Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition.
    Okano M; Konno M; Kano Y; Kim H; Kawamoto K; Ohkuma M; Haraguchi N; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2014 Aug; 45(2):575-80. PubMed ID: 24858473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
    Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
    Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.
    Harner-Foreman N; Vadakekolathu J; Laversin SA; Mathieu MG; Reeder S; Pockley AG; Rees RC; Boocock DJ
    Sci Rep; 2017 Jan; 7():40633. PubMed ID: 28094783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer.
    Ishiwata T
    Pathol Int; 2016 Nov; 66(11):601-608. PubMed ID: 27510923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.
    Ye X; Weinberg RA
    Trends Cell Biol; 2015 Nov; 25(11):675-686. PubMed ID: 26437589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy.
    Norollahi SE; Mansour-Ghanaei F; Joukar F; Ghadarjani S; Mojtahedi K; Gharaei Nejad K; Hemmati H; Gharibpoor F; Khaksar R; Samadani AA
    Biomed Pharmacother; 2019 Jul; 115():108958. PubMed ID: 31075731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines.
    Pádua Alves C; Fonseca AS; Muys BR; de Barros E Lima Bueno R; Bürger MC; de Souza JE; Valente V; Zago MA; Silva WA
    Stem Cells; 2013 Dec; 31(12):2827-32. PubMed ID: 24022994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.